| Symbol | SEER |
|---|---|
| Name | SEER, INC. |
| Sector | INDUSTRIALS |
| Region | North America |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Address | 3800 BRIDGE PARKWAY,SUITE 102, REDWOOD CITY, California, 94065, United States |
| Telephone | +1 650 453-0000 |
| Fax | — |
| — | |
| Website | https://www.seer.bio |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001726445 |
| Description | Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. Additional info from NASDAQ: |
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees
Read moreNew Form DEFA14A - Seer, Inc. <b>Filed:</b> 2026-07-08 <b>AccNo:</b> 0001193125-26-298034 <b>Size:</b> 1 MB
Read moreNew Form DEFA14A - Seer, Inc. <b>Filed:</b> 2026-07-08 <b>AccNo:</b> 0001193125-26-298033 <b>Size:</b> 34 KB
Read moreSEER Investors Have Opportunity to Join Seer, Inc. Fraud Investigation with the Schall Law Firm
Read moreNew Form DFAN14A - Seer, Inc. <b>Filed:</b> 2026-07-06 <b>AccNo:</b> 0000921895-26-001759 <b>Size:</b> 18 KB
Read moreThe Radoff-JEC Group Responds to Chairman and CEO Omid Farokhzad, M.D.’s Proposal to Acquire Seer, Inc.
Read moreSeer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential
Read moreNew Form DEFA14A - Seer, Inc. <b>Filed:</b> 2026-07-06 <b>AccNo:</b> 0001193125-26-295531 <b>Size:</b> 29 MB
Read moreSeer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
Read more